Matches in SemOpenAlex for { <https://semopenalex.org/work/W4247497579> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W4247497579 abstract "Abstract Background: In phenylketonuria (PKU), modified casein glycomacropeptide supplements (CGMP-AA) are used as an alternative to the traditional phenylalanine (Phe)-free L-amino acid supplements (L-AA). However, studies focusing on the long-term nutritional status of CGMP-AA are lacking. This retrospective study evaluated the long-term impact of CGMP-AA over a mean of 29 months in 11 patients with a mean age at CGMP-AA onset of 28 years (range 15 to 43) [8 females; 2 hyperphenylalaninaemia (HPA), 3 mild PKU, 3 classical PKU and 3 late-diagnosed]. Outcome measures included metabolic control, anthropometry, body composition and biochemical parameters. Results: CGMP-AA, providing 66% of protein substitute intake, was associated with no significant change in blood Phe with CGMP-AA compared with baseline (562 ± 289 µmol/L vs 628 ± 317 µmol/L; p =0.065). In contrast, blood tyrosine significantly increased on CGMP-AA (52.0 ± 19.2 μmol/L vs 61.4 ± 23.8 μmol/L; p =0.027). Conclusions: Biochemical nutritional markers remained unchanged which is an encouraging finding in adults with PKU, many of whom are unable to maintain full adherence with nutritionally fortified protein substitutes. Longitudinal, prospective studies with larger sample sizes are necessary to fully understand the metabolic impact of using CGMP-AA in PKU." @default.
- W4247497579 created "2022-05-12" @default.
- W4247497579 creator A5002653501 @default.
- W4247497579 creator A5016561355 @default.
- W4247497579 creator A5024426268 @default.
- W4247497579 creator A5034181421 @default.
- W4247497579 creator A5036923124 @default.
- W4247497579 creator A5037315624 @default.
- W4247497579 creator A5042466435 @default.
- W4247497579 creator A5042752242 @default.
- W4247497579 creator A5044088851 @default.
- W4247497579 creator A5048169226 @default.
- W4247497579 creator A5059518439 @default.
- W4247497579 creator A5063147881 @default.
- W4247497579 creator A5069932759 @default.
- W4247497579 creator A5075731696 @default.
- W4247497579 date "2020-11-17" @default.
- W4247497579 modified "2023-10-18" @default.
- W4247497579 title "Continuous use of glycomacropeptide in the nutritional management of patients with phenylketonuria: a clinical perspective" @default.
- W4247497579 doi "https://doi.org/10.21203/rs.3.rs-104040/v1" @default.
- W4247497579 hasPublicationYear "2020" @default.
- W4247497579 type Work @default.
- W4247497579 citedByCount "0" @default.
- W4247497579 crossrefType "posted-content" @default.
- W4247497579 hasAuthorship W4247497579A5002653501 @default.
- W4247497579 hasAuthorship W4247497579A5016561355 @default.
- W4247497579 hasAuthorship W4247497579A5024426268 @default.
- W4247497579 hasAuthorship W4247497579A5034181421 @default.
- W4247497579 hasAuthorship W4247497579A5036923124 @default.
- W4247497579 hasAuthorship W4247497579A5037315624 @default.
- W4247497579 hasAuthorship W4247497579A5042466435 @default.
- W4247497579 hasAuthorship W4247497579A5042752242 @default.
- W4247497579 hasAuthorship W4247497579A5044088851 @default.
- W4247497579 hasAuthorship W4247497579A5048169226 @default.
- W4247497579 hasAuthorship W4247497579A5059518439 @default.
- W4247497579 hasAuthorship W4247497579A5063147881 @default.
- W4247497579 hasAuthorship W4247497579A5069932759 @default.
- W4247497579 hasAuthorship W4247497579A5075731696 @default.
- W4247497579 hasBestOaLocation W42474975791 @default.
- W4247497579 hasConcept C126322002 @default.
- W4247497579 hasConcept C134018914 @default.
- W4247497579 hasConcept C185592680 @default.
- W4247497579 hasConcept C188816634 @default.
- W4247497579 hasConcept C2776142715 @default.
- W4247497579 hasConcept C2776165026 @default.
- W4247497579 hasConcept C2776263783 @default.
- W4247497579 hasConcept C2777431362 @default.
- W4247497579 hasConcept C515207424 @default.
- W4247497579 hasConcept C55493867 @default.
- W4247497579 hasConcept C61427482 @default.
- W4247497579 hasConcept C71924100 @default.
- W4247497579 hasConceptScore W4247497579C126322002 @default.
- W4247497579 hasConceptScore W4247497579C134018914 @default.
- W4247497579 hasConceptScore W4247497579C185592680 @default.
- W4247497579 hasConceptScore W4247497579C188816634 @default.
- W4247497579 hasConceptScore W4247497579C2776142715 @default.
- W4247497579 hasConceptScore W4247497579C2776165026 @default.
- W4247497579 hasConceptScore W4247497579C2776263783 @default.
- W4247497579 hasConceptScore W4247497579C2777431362 @default.
- W4247497579 hasConceptScore W4247497579C515207424 @default.
- W4247497579 hasConceptScore W4247497579C55493867 @default.
- W4247497579 hasConceptScore W4247497579C61427482 @default.
- W4247497579 hasConceptScore W4247497579C71924100 @default.
- W4247497579 hasLocation W42474975791 @default.
- W4247497579 hasLocation W42474975792 @default.
- W4247497579 hasLocation W42474975793 @default.
- W4247497579 hasOpenAccess W4247497579 @default.
- W4247497579 hasPrimaryLocation W42474975791 @default.
- W4247497579 hasRelatedWork W14815892 @default.
- W4247497579 hasRelatedWork W16136217 @default.
- W4247497579 hasRelatedWork W17506938 @default.
- W4247497579 hasRelatedWork W2666114 @default.
- W4247497579 hasRelatedWork W4269565 @default.
- W4247497579 hasRelatedWork W5242434 @default.
- W4247497579 hasRelatedWork W6350423 @default.
- W4247497579 hasRelatedWork W9635387 @default.
- W4247497579 hasRelatedWork W9702151 @default.
- W4247497579 hasRelatedWork W2489108 @default.
- W4247497579 isParatext "false" @default.
- W4247497579 isRetracted "false" @default.
- W4247497579 workType "article" @default.